[Prostate-specific antigen in serum and prostate epithelium in benign prostatic hyperplasia]

Area of Science:

• Urology
• Oncology
• Biochemistry

Context:

• Benign prostatic hyperplasia (BPH) is a common condition affecting aging men.
• Prostate-specific antigen (PSA) is a protein produced by prostate cells, and its serum levels are often used as a biomarker.
• Understanding the relationship between serum PSA and its expression in prostatic tissue is crucial for accurate diagnosis and management.

Purpose:

• To simultaneously investigate serum PSA concentrations and immune-histochemical PSA expression in benign prostatic hyperplasia (BPH) tissue.
• To compare the variability and reliability of serum PSA levels versus tissue-based PSA expression in diagnosing prostate pathology.
• To evaluate the diagnostic value of immune-histochemical PSA analysis in patients with varying degrees of BPH symptoms (IPSS).

Summary:

• The study analyzed 50 patients with BPH and 2 controls, assessing serum PSA and tissue immune-histochemical expression.
• Lumine epithelium in BPH tissue was generally PSA-positive, with expression varying from weak to high.
• Atypical hyperplasia areas, particularly those with basal cell proliferation, showed negative immune-histochemical reactions.
• Serum PSA levels exhibited greater variability than tissue expression, indicating a quantitative imbalance.
• Immune-histochemical investigation of prostatic tissue provides a more reliable assessment of prostate pathology than serum PSA alone.

Impact:

• Highlights the limitations of relying solely on serum PSA for prostate health assessment.
• Emphasizes the diagnostic utility of immune-histochemical PSA analysis for a deeper understanding of prostate pathology.
• Suggests that combined serum and tissue analysis may offer a more comprehensive approach to BPH diagnosis and management.